Benzonatate Capsule
Product Images NDC 71335-2853

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 71335-2853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352853)

Each soft gelatin capsule contains Benzonatate, USP 200 mg. This medication is recommended to be stored at 20° to 25°C (68° to 77°F) with permitted excursions between 15° to 30°C (59° to 86°F). It should be protected from light. These capsules should be swallowed whole and not broken, chewed, dissolved, cut, or crushed. The medication is dispensed in a tight, light-resistant container as per USP requirements. The package insert includes information on the usual dosage and full prescribing details for Benzonatate capsules.*

FDA Label Image

Benzonatate_chem_structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.